Description of Case {#s1}
===================

A 33-year-old man living in Cayenne, French Guiana, was admitted in the Bichat hospital in Paris with a 3-week history of fever associated with dyspnea and confusion. A chest X-ray previously made in French Guiana showed an alveolar infiltrate of the middle lobe. Amoxicillin and then doxycycline were administered, but did not alleviate the symptoms. Physical examination revealed a loss of 4 kilograms in the last month, confusion, hypotension (98/63 mmHg), tachycardia (126 beats per minute), a red but painless left eye, congestive heart failure, fine crackles in the right lung field, and a one-centimetre-wide left axillary node.

Haematological blood tests revealed a haemoglobin level of 137 g/l with signs of haemolysis (elevated lactic dehydrogenase, low haptoglobin), a total white blood cell count of 11.1×10^9^/L (69% granulocytes, 21% lymphocytes), and thrombocytosis (392×10^9^/L platelets). The blood film showed stigmata of mononucleosis syndrome. Blood chemistry revealed hyponatremia, mild hepatitis, pancreatitis, and elevated cardiac markers. [Table 1](#pntd-0001802-t001){ref-type="table"} summarizes biological data.

10.1371/journal.pntd.0001802.t001

###### Laboratory findings.
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  Biological Characteristics                                              Day 1                   Day 6                  Day 19   Day 41    Day 60          Normal Values
  --------------------------------------------------------------------- ---------- ------------------------------------ -------- -------- ---------- ---------------------------
  Natremia (mmol/L)                                                        127                     125                    133      140       140              135--145
  Blood osmolarity (mosmol/L)                                              259      na[1](#nt101){ref-type="table-fn"}     na       na        na              300--310
  Urine osmolarity (mosmol/l)                                              508                      na                     na       na        na              500--100
  Thyroid stimulating hormone (mIU/L)                                      1.9                      na                     na       na        na              0.3--5.0
  Cortisol[2](#nt102){ref-type="table-fn"} (nmol/L)                        598                      na                     na       na        na              138--745
  Aspartate aminotransferase (IU/L)                                        118                      83                    233       55        46                \<40
  Alanine aminotransferase (IU/L)                                           97                      86                    189       46        45                \<40
  Gamma-glutamyl transpeptidase (IU/L)                                     127                      76                    245       27        27                \<58
  Alkaline phosphatase (IU/L)                                               66                      51                    119       34        na                \<34
  Total bilirubin (micromol/L)                                              17                      13                     9        10        na                \<17
  Troponin (microg/L)                                                      1.59                    0.36                    na      0.05       na                \<0,6
  Brain natriuretic peptide (ng/L)                                        1,510                    274                     na      258        na                \<100
  Lipase (IU/L)                                                            503                    1,142                   771      283        0                 \<60
  Lactic dehydrogenase (U/L)                                              1,978                     na                     na       na        na                \<470
  Haptoglobin (g/L)                                                        0.1                      na                     na       na        na              0.64--1.7
  Creatinine phosphokinase (IU/L)                                          340                      na                     na       na        na               10--200
  Anti-*Toxoplasma* IgG (IU/mL)[3](#nt103){ref-type="table-fn"}             68                     147                    199      785       294        positive if \>4 IU/mL
  Anti-*Toxoplasma* IgM (index)[3](#nt103){ref-type="table-fn"}            42.7                     45                     38       45        45         positive if \>0.75
  Anti-*Toxoplasma* IgG Avidity index[4](#nt104){ref-type="table-fn"}      0.04                     na                     na       na        na      recent infection if \<0.3
  *Toxoplasma* PCR in blood                                              positive                   na                     na       na     negative           negative

Not available.

8:00 am measurement.

Vidia Biomérieux.

Vidas Biomérieux.

Electrocardiogram showed sinus tachycardia. Transthoracic echocardiography revealed an altered left ventricular ejection fraction (35% estimation with Simpson\'s method), global hypokinesia, but no signs of endocarditis. Abdominal computed tomography (CT) scanner was normal.

What Further Investigations Would You Perform to Make Etiological Diagnosis? {#s2}
============================================================================

There are many diagnoses that can lead to subacute fever, hepatitis, pancreatitis, and pneumonia in a patient coming from the Amazonian region. Blood cultures, thick and thin smears for malaria, and intradermal purified protein derivative test for tuberculosis were negative. *Mycobacterium tuberculosis* was not detected on gastric aspirates. Urines were sterile, and antigen detection for *Streptococcus pneumoniae* and *Legionella pneumophila* was negative. *HIV*, *hepatitis viruses* (*A*, *B*, and *C*), *Coxiella burnetti*, *Rickettsia conorii*, *Salmonella typhi and paratyphi*, *Brucella sp.*, *Dengue fever*, and *Mumps virus* serologies were also negative. *Chlamydia pneumoniae* and *Mycoplasma pneumonia* serologies were positive with the presence of both IgM and IgG. *Epstein-Barr virus (EBV)*-IgM and IgG anti-VCA antibodies were also found, but detection of *EBV* and *Cytomegalovirus* (*CMV*) DNA by polymerase chain reaction (PCR) was negative. Since the patient had severe cardiac dysfunction, Chagas\' disease was also looked for, but antibodies against *Trypanosoma cruzi* were absent. Cerebrospinal fluid analysis revealed 8 cells/mm3, hypoglycorrhacchia (2.3 mmol/L with venous glycaemia 5.5 mmol/L), hyperproteinorrachia (0.54 g/L), sterile culture, and negative pneumococcal and cryptococcal antigen detection. *Toxoplasma gondii*, *Herpes simplex viruses* (*type-1* and *-2*), *EBV*, and *Varicella-zoster virus* DNA were not detected by PCR in the cerebrospinal fluid.

What Finally Led to Diagnosis? {#s3}
==============================

The patient reported the consumption of semi-raw game (Brazilian Tapir, *Tapirus terrestris*, locally known as Maïpouri) 3 weeks before the beginning of symptoms, pieces of which were still kept frozen.

Ophthalmologic examination showed a cornea ulcer associated with multiple foci of retinochoroiditis in the left eye, which is suggestive of toxoplasmosis.

Systematic exploration of the causes of mononucleosis syndrome led (besides *HIV*, *EBV*, and *CMV* serologies) to *T. gondii* serology, which was positive with the presence of IgG (63 IU/ml), high levels of IgM (index of 42.7, Vidia Biomerieux), and IgA (12/12 with ISAGA Biomerieux test). The avidity of anti-toxoplasmic IgG was low (4% Vidas Biomerieux). These data suggested recent toxoplasmosis infection. [Table 1](#pntd-0001802-t001){ref-type="table"} summarizes serological data.

How Can Hyponatremia and Hemolysis Be Explained? {#s4}
================================================

Since blood osmolarity was low (259 mosmol/L) and urine osmolarity was high (508 mosmol/L), the syndrome of inappropriate antidiuretic hormone secretion (SIADH) was suspected. Cortisol response to synacthen test and level of serum thyroid-stimulating hormone were normal. No medication causing hyponatremia as a side effect was taken. Brain magnetic resonance imaging was normal, and full-body CT scan did not suspect cancer. SIADH diagnosis was confirmed and related to pneumonia.

There were no schizocytes on the blood film. Direct Coombs\' test and hemoglobin electrophoresis were negative or normal. Pyruvate kinase deficiency and Minkowski-Chauffard disease were also looked for but excluded. Glutathione stability test revealed mild g6pd deficiency (7% g6pd activity). The patient, though living in French Guiana, was of Chinese descent, and g6pd deficiency is frequent in Asia. Amoxicillin and doxycycline are suitable for g6pd patients, and we can imagine that sepsis favored haemolysis.

How Would You Manage the Patient? {#s5}
=================================

When *C. pneumonia* and *M. pneumoniae* serologies came back positive, macrolide therapy (roxithromycine 300 mg/day) was started. However, physicians doubted that these serological data could explain the whole symptoms. Three weeks after the first serologies, *C. pneumonia* and *M. pneumoniae* antibodies\' rates did not rise, pointing out a cross-serological reactivity with *T. gondii* antibodies.

Since the patient was in a critical condition and despite mild g6pd deficiency, gold standard anti-toxoplasmosis treatment [@pntd.0001802-Montoya1] was promptly started after the serological diagnosis of recent *T. gondii* infection. The patient\'s condition improved with pyrimethamine (100 mg/day for the first 2 days followed by 50 mg/day), sulfadiazine (6 g/day), and folinic acid (25 mg/day). There was no increased haemolysis with sulfadiazine, but this drug was stopped and replaced by clindamycin (2.4 g/day) due to hepatotoxicity. Anti-*Toxoplasma* drugs were given for a total of 6 weeks.

A salt-free diet, furosemide, and increased doses of perindopril and bisoprolol were also administered. Heart rate diminished, congestive heart failure symptoms disappeared, and brain natriuretic peptide and troponin levels normalized. Periodic transthoracic echocardiogram evaluations were performed and LVEF measures reached 45% at the patient\'s discharge.

When furosemide was stopped, and thanks to fluid deprivation, natremia normalized. The patient recovered his full intellectual abilities.

With anti-*Toxoplasma* treatment and Vitamin A ointment, cornea ulcer and chorioretinitis healed without visual aftereffect.

Lipase rose to 17N but decreased under antiparasitic therapy.

Additional Molecular and Parasitological Investigations {#s6}
=======================================================

A quantitative PCR-based assay detected the 200- to 300-fold repetitive 529 bp DNA fragment of *T. gondii* in a blood sample collected 3 days after admission. This blood sample was also inoculated into mice. Four weeks post-inoculation, all mice tested positive for *T. gondii* antibodies and showed signs of disease due to a virulent *T. gondii* strain.

All surviving inoculated mice were sacrificed and numerous *T. gondii* cysts were microscopically observed in the brain samples. Cell cultures were inoculated with trypsinized cysts of *T. gondii*, and the strain was named BRC TgH41001.

Genotyping analysis with 15-microsatellite markers [@pntd.0001802-Ajzenberg1] of the BRC TgH41001 strain was performed on DNA extracted from cysts collected at first isolation in mice. In each pair, one primer was 5′-end labelled with fluorescein (6-FAM, HEX, or NED) to allow sizing of PCR products with an automatic sequencer. PCR was carried out in a 25-µL-reaction mixture consisting of 12.5 µL of 2X QIAGEN Multiplex PCR Master Mix (Qiagen) and 5 pmol each primer. Cycling conditions were 15 min at 95°C, 30 s at 94°C, 3 min at 61°C, 30 s at 72°C (35 cycles), and 30 min at 60°C. PCR products were diluted in desionised formamid with a dye-labeled size standard (ROX 500, Applied Biosystems) and electrophoresed using an automatic sequencer (Abiprism 3100, Applied Biosystems). The sizes of the alleles in base pairs (bp) were estimated using GeneMapper analysis software (version 4.0, Applied Biosystems).

Total DNA was extracted on eight samples of the frozen Maïpouri meat and submitted to a quantitative PCR-based assay targeting the 200- to 300-fold repetitive 529 bp DNA fragment of *T. gondii*, but only one tested repeatedly positive for *T. gondii* DNA at low concentration (cycle thresholds of 35.74 and 36.05). The genotyping analysis with 15 single-copy microsatellite markers was attempted on this positive DNA sample but was unsuccessful because the amount of *T. gondii* DNA was too low for a successful amplification of the genetic markers.

The genotyping data of the BRC TgH41001 strain and 12 reference strains are reported in [Table 2](#pntd-0001802-t002){ref-type="table"}. Phylogenetic analyses of *T. gondii* strains have shown that those from the French Guianan rainforest are of special significance because they are genetically highly divergent from the ones found elsewhere in the world [@pntd.0001802-Khan1] and even from those circulating along the coastline of French Guiana [@pntd.0001802-Mercier1]. The genotyping analysis of TgH41001 strain supports this viewpoint. This strain possesses a specific combination of microsatellite alleles (such as alleles 203 and 246 at *TgM-A* and *W35* markers, respectively), which to date has been described only in the atypical strains from the Amazonian rain forest (Daniel Ajzenberg, personal communication).

10.1371/journal.pntd.0001802.t002

###### Genotyping results of BRC TgH41001 strain and 12 reference strains with 15 microsatellite markers.

![](pntd.0001802.t002){#pntd-0001802-t002-2}

                                                      Microsatellite Markers                                                                                
  ---------- -------------- --------------- -------- ------------------------ ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- ----- -----
  Atypical    BRC TgH41001   French Guiana   Human             291             246   203   158   346   169   272   356   229   172   142   105   261   105   316
  I               CT1             USA         Cow              291             248   209   160   342   169   274   358   209   168   145   119   265   87    306
  II              PTG             USA        Sheep             289             242   207   158   336   169   274   356   215   174   142   111   265   91    310
  III             CTG             USA         Cat              289             242   205   160   336   165   278   356   215   190   147   111   269   89    312
  Atypical       COUGAR         Canada       Cougar            289             242   205   158   336   169   274   354   219   174   151   119   259   79    332
  Atypical      TgCatBr1        Brazil        Cat              289             242   205   160   342   165   278   358   233   164   147   111   316   89    308
  Atypical      TgCatBr3        Brazil        Cat              289             242   205   160   348   165   278   356   213   190   142   111   263   113   312
  Atypical      TgCatBr5        Brazil        Cat              291             242   205   160   362   165   278   356   237   174   140   111   265   89    314
  Atypical        RUB        French Guiana   Human             289             242   205   170   360   167   274   356   223   190   142   109   259   85    312
  Atypical        VAND       French Guiana   Human             291             242   203   162   344   167   276   356   217   170   142   113   277   91    308
  Atypical    BRC TgH18001   French Guiana   Human             289             246   203   160   344   167   272   356   229   176   142   113   263   85    312
  Atypical    BRC TgH18002   French Guiana   Human             289             246   203   160   337   165   274   356   209   172   136   111   251   109   310
  Atypical    BRC TgH18003   French Guiana   Human             291             242   203   160   339   165   272   358   221   174   138   107   277   95    312

PTG is a clone of the ME49 strain; CTG is also known as CEP or C strain; COUGAR is also known as TgCgCa1 or COUG strain; BRC TgH18001 is also known as GUY-DOS or GUY-2001-DOS strain; BRC TgH18002 is also known as GUY-KOE or GUY-2002-KOE strain; BRC TgH18003 is also known as GUY-MAT or GUY-2002-MAT.

Why Was the Patient\'s State So Severe? {#s7}
=======================================

One of the evolutionary strengths of *T. gondii* is its ability to adapt its reproductive behaviour in different environments. In North America and Western Europe, it benefits from ancient agricultural habits of breeding of a limited number of species, which provide a stable environment. The latter is ideal for asexual reproduction, thus leading to clonal propagation of a few successful lineages [@pntd.0001802-Ajzenberg2]. In these areas, 95% of *T. gondii* strains belong to three main lineages named type I, II, and III.

On the contrary, the Amazonian rainforest ecosystem is a hotbed of diversity. In order to survive in such an environment, *T. gondii* uses preferentially sexual reproduction in wild felids\' gastrointestinal tract to generate atypical strains with highly divergent genotypes [@pntd.0001802-Ajzenberg2]. The report of an atypical *T. gondii* strain isolated in a free-living jaguar in French Guiana supports the existence of a *T. gondii* wildlife cycle and then genetic diversity [@pntd.0001802-Demar1]. Since 1998, several severe (and sometimes lethal) cases of acute toxoplasmosis in immunocompetent subjects involving such strains have been reported in French Guiana [@pntd.0001802-Dard1]--[@pntd.0001802-Demar2]. They disseminate via parasitaemia to multiple organs and especially to the lungs [@pntd.0001802-Demar2].

So far, there are only epidemiological and clinical data [@pntd.0001802-Demar2] supporting the fact that atypical Guianan strains are more virulent in immunocompetent patients than other *T. gondii* strains. Their high genetic diversity may provide them with enhanced invasive abilities, or it could interfere with the Th1 host immune response, as suggested by experiments in mouse models [@pntd.0001802-Taylor1]--[@pntd.0001802-Fentress1]. However, evidence has also been given indicating interindividual variability after infection to a same Guianan strain in an outbreak [@pntd.0001802-Demar3]. Biochemical mechanisms of virulence have not yet been studied in humans, but experimentally, ROP proteins seem to be essential for invasion and maintenance of the parasitophorous vacuole membrane. It has been shown that the overexpression of *ROP18* or the transfection of the *ROP18* allele into a nonpathogenic *T. gondii* strain enhances mortality in a mouse model [@pntd.0001802-Taylor1]--[@pntd.0001802-Fentress1]. Further studies, such as the *ROP18* gene sequencing of atypical Guianan strains, would be of high scientific value.

Source of Infection {#s8}
===================

There is no formal evidence that the Maïpouri meat was the source of infection. Nonetheless, many strong arguments support this view. First, previous studies [@pntd.0001802-Carme2] demonstrated that consumption of game from the Amazonian forest was strongly associated with the risk of developing 10 to 20 days later severe toxoplasmosis. Second, we have proved that there was *T. gondii* DNA in the Maïpouri sample. Third, the patient ate undercooked meat, which makes highly likely the fact that he ingested living *T. gondii* cysts. Finally, and despite thorough questioning, we could not identify any other potential source of *T. gondii* infection. The patient was living in an urban area, without any pets, and has never travelled to the Amazonian rainforest. He drank only boiled water and did not report any other raw-meat consumption in the month before the beginning of symptoms besides the Maïpouri steak. To our knowledge, evidence has never been published demonstrating that a piece of meat was the source of human *Toxoplasma* infection by matching the parasite\'s genotype from the patient\'s biological sample and from a piece of meat likely to be the source of infection.

Among the five people who shared the Maïpouri dish, only two ate undercooked meat: the patient and his father. The latter remained asymptomatic, but he refused to perform a test to check his serological status against toxoplasmosis. Only hypotheses can be made to explain why he remained healthy. Either his steak was free of *T. gondii* cyst or most probably, thanks to his age, he was already immunized against toxoplasmosis.

Conclusion {#s9}
==========

In medical practice, *T. gondii* is mainly a health concern in pregnant women and in immunosuppressed patients. In immunocompetent patients, acute toxoplasmosis is generally asymptomatic or associated with benign symptoms such as prolonged fever, polyadenopathy, and myalgia. Severe complications, such as pneumonia, myocarditis, or meningo-encephalitis, are infrequent. Eye involvement is likely underestimated, and the burden of ocular toxoplasmosis seems to be extremely high in certain tropical areas of South America [@pntd.0001802-Jones1].

To date, more than a hundred cases of acute toxoplasmosis in immunocompetent patients (adults and children) due to atypical strains of *T. gondii* have been reported in French Guiana (M. Demar, personal data). Approximately 40 have been published. It is highly likely that these atypical and virulent strains of *T. gondii* also exist in other Amazonian countries than French Guiana, but clinical cases are probably underreported.

Physicians should systematically consider acute toxoplasmosis as a possible diagnosis for any infectious syndrome with visceral (especially lung) involvement in patients who have recently travelled to or lived in the Amazonian area. Since lethal cases have been reported and since treatment associating pyrimethamine and sulfadiazine is efficient, such treatment should be promptly started immediately after serological results, without waiting for positive PCR or parasitic isolation.

Key Learning Points {#s10a}
-------------------

-   Atypical and highly virulent strains circulating in the Amazonian rainforest ecosystem

-   To date only described in French Guiana but likely underreported in other countries of the Amazonian area

-   Lung involvement is frequent and lethal cases have been described

-   Specific anti-toxoplasmosis treatment should be promptly started immediately after serological results, without waiting for positive PCR or parasitic isolation
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